Management of a 44-Year-Old Female with Hematologic Abnormalities
The next step in management should be iron supplementation to address the iron deficiency, followed by vitamin B12 and vitamin D supplementation, while investigating the underlying cause of the erythrocytosis and thrombocytosis. 1
Initial Assessment and Interpretation of Findings
- The patient presents with a constellation of hematologic abnormalities: high red blood cell count (erythrocytosis), high hematocrit, high platelets (thrombocytosis), normal hemoglobin, and deficiencies in ferritin, vitamin B12, and vitamin D 1
- This pattern suggests a complex picture with multiple nutritional deficiencies alongside a paradoxical increase in red blood cells and platelets 1
- The normal hemoglobin despite high RBC count indicates that the cells may be microcytic or hypochromic due to iron deficiency 1
Management Algorithm
Step 1: Address Iron Deficiency
- Begin oral iron supplementation with 45-60 mg of elemental iron daily 1
- Low ferritin (40) confirms iron deficiency, which requires immediate treatment 1
- Monitor response with reticulocyte count within 1-2 weeks of starting therapy 1
- Consider evaluation for sources of blood loss, particularly gastrointestinal, as iron deficiency in adults often indicates occult bleeding 1
Step 2: Correct Vitamin B12 Deficiency
- Initiate vitamin B12 supplementation with oral cyanocobalamin 1000 mcg daily 2, 3
- Although the patient's B12 level (307) is low-normal, supplementation is warranted given the hematologic abnormalities 2
- Monitor for improvement in blood counts and neurologic symptoms if present 2
- Avoid folic acid supplementation without concurrent B12 supplementation as it may mask B12 deficiency while allowing neurologic damage to progress 2
Step 3: Address Vitamin D Deficiency
- Start vitamin D supplementation with 1000-2000 IU daily 1
- Low vitamin D (53.7) should be corrected to optimize bone health and immune function 1
Step 4: Further Investigation
- Complete a comprehensive workup for the cause of erythrocytosis and thrombocytosis 1
- Order complete blood count with red cell indices, reticulocyte count, peripheral blood smear, and inflammatory markers (CRP) 1
- Consider bone marrow examination if blood counts do not improve with nutritional supplementation 1
- Evaluate renal function, as chronic kidney disease can contribute to hematologic abnormalities 1
- Screen for myeloproliferative disorders, particularly if counts remain elevated after correction of deficiencies 1
Monitoring and Follow-up
- Recheck complete blood count, ferritin, and transferrin saturation in 4-6 weeks 1
- Monitor reticulocyte count as a marker of response to therapy 1
- If anemia persists despite iron and B12 supplementation for 4 weeks, evaluate for other contributing factors 1
- Assess blood pressure regularly, as the patient is on amlodipine for hypertension, and anemia treatment may affect blood pressure control 1
Special Considerations
- The combination of iron deficiency with elevated RBC count and platelets is unusual and suggests a possible reactive process or underlying hematologic disorder 4, 5
- Persistent anemia after appropriate supplementation requires further evaluation for other causes such as chronic inflammation, malignancy, or rare nutritional deficiencies 1, 6
- Consider screening for celiac disease or other malabsorption disorders if nutritional deficiencies persist despite adequate supplementation 1
- The paradoxical finding of normal hemoglobin with high RBC count may represent a compensatory mechanism in the setting of chronic iron deficiency 7